Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-21

Clinical Trial Update: Oral Progesterone for Prevention of Preterm Birth [Phase 3]

View source ↗

Summary

This update reports Phase 3 clinical trial results for oral progesterone to prevent preterm birth, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Progesterone (oral) (progesterone)

Snippet

Sponsor: Fetal Medicine Foundation | Conditions: Preterm Birth | Phase 3 | Status: COMPLETED | Results posted: 2011-07-21